Revive Therapeutics Grants 15.5 Million Stock Options

Revive Therapeutics Ltd., a Toronto-based life sciences company, has announced the grant of 15,500,000 incentive stock options. These options have been allocated to key team members, including directors, officers, and consultants. The exercise price is set at $0.05 per share, valid for five years.

This decision aligns with Revive's strategy of enhancing performance and motivating excellence among its team as the company advances its research in therapeutics for biodefence and pandemic preparedness. The options are part of the company's 10% rolling stock option plan and adhere to the regulations of the CSE.